Implementation challenges of eliminating preferential currency in Iran’s pharmaceutical sector
Before the implementation of Darooyar, Iran’s pharmaceutical sector relied heavily on preferential foreign-exchange allocation for imported medicines and pharmaceutical inputs, while the system faced broader challenges related to financing, affordability, and medicine supply. In this context, the Darooyar plan was introduced to eliminate preferential currency and replace it with a targeted pharmaceutical subsidy mechanism intended to improve the sustainability and transparency of pharmaceutical financing. This study aimed to explore the challenges associated with eliminating preferential currency in Iran’s pharmaceutical sector, with particular attention to financing, governance, stakeholder relationships, and pharmaceutical supply-chain pressures. A qualitative study employing descriptive content analysis was conducted in 2025 to explore the challenges associated with eliminating preferential currency in Iran’s pharmaceutical sector, with particular attention to financing, governance, stakeholder relationships, and pharmaceutical supply-chain pressures. Participants included policymakers, executive managers, insurance specialists, pharmacy technical officers, and pharmaceutical manufacturers. Purposive sampling with a snowball approach was applied, yielding 27 participants. Data were collected through semi-structured interviews using an interview guide. Data collection and analysis were performed concurrently using Atlas.ti software. Five overarching themes, 21 subthemes, and 73 codes were identified regarding the challenges of implementing the policy. The main themes comprised: (1) Weaknesses in policy design, management, planning, and implementation; (2) Reported irregularities, misconduct, and inadequate oversight within the pharmaceutical system; (3) stakeholder dissatisfaction and constraints; (4) financial problems across the pharmaceutical supply chain; and (5) Macroeconomic and policy pressures on pharmaceutical system sustainability. Recommendations include strengthening technological infrastructure (integrated insurance systems and reliable internet), targeted education and communication, establishing independent expert oversight, ensuring sustainable budget allocation with timely online payments, and conducting pilot implementations with continuous evaluation prior to nationwide rollout.
Authors
- Mohsen Bayati (ORCID: https://orcid.org/0000-0002-9118-5447)
- Seyyed Morteza Mojtabaeian (ORCID: https://orcid.org/0000-0002-9812-599X)
- Mohammad Javad Taghipour (ORCID: https://orcid.org/0000-0003-0631-4505)
- Sajad Delavari
- Farhad Lotfi
Institutions
- Shiraz University of Medical Sciences (IR)
Publication Details
- Journal
- Scientific Reports
- Published
- 2026-11-16
- DOI
- https://doi.org/10.1038/s41598-026-79155-0
- Primary Topic
- Pharmaceutical Economics and Policy
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Institute for Health and Care Excellence
- Shiraz University of Medical Sciences